Quality is in the eye of the beholder. Clinical image interpretation is paramount as we’ve talked about before. But there are other aspects to demonstrating quality for your partners.
Quality is in the eye of the beholder. Clinical image interpretation is paramount as we’ve talked about before. But there are other aspects to demonstrating quality for your partners.
Slow service is poor service. We want accuracy, but delivered as fast as possible. That means improving your TAT, or turn-around time. Most of us are now quite familiar with this. Many colleagues see it as onerous cloud. Don’t look at that way.
TAT is an easy mark for you. Set a goal as a group and work toward it. Showing improvement in such numerical ways is also regarded as value added. Look to industry standards for this and target those. Or use historical group or hospital values as a baseline on which to improve.
Keep state of the art. Quality includes being up to date. We all realize that is a challenge. I am constantly told of new things that I have not heard about. So what do you do practice-wide? And how do you spin that to be value added to your partners?
First, make yourself available for all technical questions and purchases as a consultant to the hospital or imaging centers with which you work. Assign each modality to someone in the group as their area of expertise. Designate them to address questions about protocols and new hardware options. Require them to provide regular, perhaps annual updates about new options. Create a technology committee of two to three individuals who will be leaders for larger purchases. Set aside time for the modality leaders to work with vendors and employ new software.
In short, make the center or hospital work better - at no extra charge. And don’t forget to remind them politely that you are!
Internally, require CME in areas of expertise from your staff. Create incentives that encourage everyone to attend meetings regularly. Consider an annual retreat where each group member presents relevant new information for the group. Again, rigor such as this lifts everyone, and is something concrete to provide the hospital as evidence of your high quality.
Don’t forget about the technical side. This can be one of the trickiest aspects of quality. I have been faced with criticism from administration on several occasions about harsh treatment of technical staff. Invariably this follows after I have admonished them for poor performance.
How do you avoid this? Be pro-active. Work with the administration, including the heads of each modality on the technical side, to create a system that works. Anonymous criticism is often ineffective and met with resistance. By the same token, a frustrated rant by the MD about something that is a repetitive error is usually not received well.
Encourage the radiologists to point out technical deficiencies, and have one radiologist who is involved in the review process. Look for trends. Then, hold regular teaching sessions with staff in each modality and use examples. Teach, don’t criticize, and you’ll see improvement. The hospital will thank you and see clearly that you are adding value, by adding quality.
New Study Examines Short-Term Consistency of Large Language Models in Radiology
November 22nd 2024While GPT-4 demonstrated higher overall accuracy than other large language models in answering ACR Diagnostic in Training Exam multiple-choice questions, researchers noted an eight percent decrease in GPT-4’s accuracy rate from the first month to the third month of the study.
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.